• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分离鉴定一株人肠道茵转化大豆苷元的茵株

Isolation and identification of a human intestinal bacterium capable of daidzein conversion.

机构信息

College of Food Science, South China Agricultural University, Guangzhou, China.

Guangdong Provincial Key Laboratory of Nutraceuticals and Functional Foods, College of Food Science, South China Agricultural University, Guangzhou, China.

出版信息

FEMS Microbiol Lett. 2021 May 11;368(8). doi: 10.1093/femsle/fnab046.

DOI:10.1093/femsle/fnab046
PMID:33930123
Abstract

Equol, which produced from daidzein (one of the principal isoflavones), is recognized to be the most resultful in stimulating an estrogenic and antioxidant response. The daidzein transformation was studied during fermentation of five growth media inoculated with feces from a healthy human, and a daidzein conversion strain was isolated. To enrich the bacterial population involved in daidzein metabolism in a complex mixture, fecal samples were treated with antibiotics. The improved propidium monoazide combined with the quantitative polymerase chain reaction (PMAxx-qPCR) assay showed that the ampicillin treatment of samples did result in a reduction of the total visible bacteria counts by 52.2% compared to the treatment without antibiotics. On this basis, the newly isolated rod-shaped, Gram-positive anaerobic bacterium, named strain Y11 (MN560033), was able to metabolize daidzein to equol under anaerobic conditions, with a conversion ratio (equol ratio: the amount of equol produced/amount of supplemented daizein) of 0.56 over 120 h. The 16S rRNA partial sequence of the strain Y11 exhibited 99.8% identity to that of Slackia equolifaciens strain DZE (NR116295). This study will provide new insights into the biotransformation of equol from daidzein by intestinal microbiota from the strain-level and explore the possibility of probiotic interventions.

摘要

雌马酚是大豆异黄酮之一,其代谢产物,被认为是最有效的雌激素和抗氧化剂反应刺激物。本研究通过在五种接种有健康人体粪便的生长培养基中发酵大豆苷元,来研究其在发酵过程中的转化,同时分离出大豆苷元转化菌株。为了在复杂混合物中富集参与大豆苷元代谢的细菌种群,对粪便样本进行了抗生素处理。改良的吖啶橙单重荧光定量聚合酶链反应(PMAxx-qPCR)检测表明,与未用抗生素处理的样本相比,氨苄青霉素处理的样本中总可见细菌计数减少了 52.2%。在此基础上,从粪便中分离出一种新的杆状、革兰氏阳性、厌氧细菌,命名为 Y11 株(MN560033),该菌株能够在厌氧条件下将大豆苷元代谢为雌马酚,在 120 小时内的转化率(雌马酚比:产生的雌马酚量/添加的大豆苷元量)为 0.56。菌株 Y11 的 16S rRNA 部分序列与 Slackia equolifaciens 菌株 DZE(NR116295)的序列具有 99.8%的同一性。本研究将从菌株水平深入了解肠道微生物群对大豆苷元转化为雌马酚的生物转化,并探索益生菌干预的可能性。

相似文献

1
Isolation and identification of a human intestinal bacterium capable of daidzein conversion.分离鉴定一株人肠道茵转化大豆苷元的茵株
FEMS Microbiol Lett. 2021 May 11;368(8). doi: 10.1093/femsle/fnab046.
2
Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria.两种人类肠道细菌共培养体系中C-葡萄糖基异黄酮葛根素向雌激素(3S)-雌马酚的生物转化
Biol Pharm Bull. 2008 Aug;31(8):1621-5. doi: 10.1248/bpb.31.1621.
3
Lactulose promotes equol production and changes the microbial community during in vitro fermentation of daidzein by fecal inocula of sows.乳果糖促进黄豆苷元在母猪粪便接种物体外发酵中产.equol 和改变微生物群落。
Anaerobe. 2014 Feb;25:47-52. doi: 10.1016/j.anaerobe.2013.11.011. Epub 2013 Dec 4.
4
Isolation of a human intestinal bacterium capable of daidzein and genistein conversion.一株能够转化大豆苷元和染料木黄酮的人肠道细菌的分离
Appl Environ Microbiol. 2009 Mar;75(6):1740-4. doi: 10.1128/AEM.01795-08. Epub 2009 Jan 9.
5
Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces.从人类粪便中分离出一株代谢异黄酮的类梭状芽孢杆菌TM-40。
Anaerobe. 2007 Feb;13(1):32-5. doi: 10.1016/j.anaerobe.2006.10.001. Epub 2006 Nov 17.
6
[Microbial conversion of daidzein affects fecal equol concentration and bacterial composition of rats with or without ovariectomy].[大豆苷元的微生物转化对去势和未去势大鼠粪便中雌马酚浓度及细菌组成的影响]
Wei Sheng Wu Xue Bao. 2012 Jul 4;52(7):866-74.
7
Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol.迟缓埃格氏菌(Slackia equolifaciens)sp. nov.,一种能够产生雌马酚的人类肠道细菌。
Int J Syst Evol Microbiol. 2010 Aug;60(Pt 8):1721-1724. doi: 10.1099/ijs.0.016774-0. Epub 2009 Sep 4.
8
Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine.从大鼠肠道分离出的革兰氏阳性杆状细菌将大豆苷元转化为雌马酚。
J Biosci Bioeng. 2006 Sep;102(3):247-50. doi: 10.1263/jbb.102.247.
9
Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones.服用大豆异黄酮的产雌马酚和不产雌马酚绝经后女性粪便培养物中的细菌群落和代谢活性
BMC Microbiol. 2017 Apr 17;17(1):93. doi: 10.1186/s12866-017-1001-y.
10
Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine.从小鼠肠道新分离出的一种厌氧菌对大豆苷元和染料木黄酮的转化作用。
Appl Environ Microbiol. 2008 Aug;74(15):4847-52. doi: 10.1128/AEM.00555-08. Epub 2008 Jun 6.

引用本文的文献

1
Equol: a metabolite of gut microbiota with potential antitumor effects.雌马酚:一种具有潜在抗肿瘤作用的肠道微生物群代谢产物。
Gut Pathog. 2024 Jul 7;16(1):35. doi: 10.1186/s13099-024-00625-9.
2
Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions.探索底物-微生物相互作用:一种开发靶向共生组合的代谢共生方法。
Gut Microbes. 2024 Jan-Dec;16(1):2305716. doi: 10.1080/19490976.2024.2305716. Epub 2024 Feb 1.
3
Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis.
木质素多酚生物利用度与大豆异黄酮代谢肠型的关联:一项横断面分析。
PLoS One. 2023 Dec 4;18(12):e0295185. doi: 10.1371/journal.pone.0295185. eCollection 2023.
4
Association between urinary zinc excretion and isoflavone-metabolizing enterotypes among Japanese females: a cross-sectional study.尿锌排泄与日本女性大豆异黄酮代谢肠型的关系:一项横断面研究。
Environ Health Prev Med. 2023;28:63. doi: 10.1265/ehpm.23-00148.
5
Advances in the Metabolic Mechanism and Functional Characteristics of Equol.雌马酚的代谢机制及功能特性研究进展
Foods. 2023 Jun 10;12(12):2334. doi: 10.3390/foods12122334.
6
An improved whole-cell biotransformation system for ()-equol production.一种用于生产()-雌马酚的改进型全细胞生物转化系统。 (括号部分原文缺失具体内容)
Food Sci Nutr. 2022 Mar 21;10(7):2318-2324. doi: 10.1002/fsn3.2840. eCollection 2022 Jul.